Pacific Biosciences of California PACB Common stock, par value (in dollars per share)
Common stock, par value (in dollars per share) at other companies
Other financials
Where this comes from
Reported directly by Pacific Biosciences of California in its filing.
Tagged under the XBRL concept us-gaap:CommonStockParOrStatedValuePerShare.
The official record: Pacific Biosciences of California’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about Pacific Biosciences of California's common stock, par value (in dollars per share).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Pacific Biosciences of California's common stock, par value (in dollars per share)?
- Pacific Biosciences of California (PACB) reported common stock, par value (in dollars per share) of $0 in Q1 2026.
- How has Pacific Biosciences of California's common stock, par value (in dollars per share) changed year-over-year?
- Pacific Biosciences of California's common stock, par value (in dollars per share) decreased by 0.0% year-over-year, from $0 to $0.
- What is the long-term trend for Pacific Biosciences of California's common stock, par value (in dollars per share)?
- Over 5 years (2020 to 2025), Pacific Biosciences of California's common stock, par value (in dollars per share) has grown at a 0.0% compound annual growth rate (CAGR), from $0 to $0.